Pifeltro and Dizziness - a phase IV clinical study of FDA data

Summary:

Dizziness is reported as a side effect among people who take Pifeltro (doravirine), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Biktarvy, and have Hiv infection.

The phase IV clinical study analyzes which people have Dizziness when taking Pifeltro. It is created by eHealthMe based on reports of 470 people who have side effects when taking Pifeltro from the FDA, and is updated regularly.

What is Pifeltro?

Pifeltro has active ingredients of doravirine. eHealthMe is studying from 476 Pifeltro users. Check the latest studies of Pifeltro.

What is Dizziness?

Dizziness is found to be associated with 3,571 drugs and 5,711 conditions by eHealthMe. Check the latest studies of Dizziness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 01, 2026

470 people reported to have side effects when taking Pifeltro.
Among them, 12 people (2.55%) have Dizziness.

Among these 12 people:

How long have people been on Pifeltro when they have Dizziness? *

What is the gender of people who have Dizziness when taking Pifeltro? *

female: 9.09 %
male: 90.91 %

What is the age of people who have Dizziness when taking Pifeltro? *

What are other drugs people take besides Pifeltro? *

What are other side effects people have besides Dizziness? *

Fainting (loss of consciousness and postural tone): 3 people, 25.00%
Lipase Abnormal: 3 people, 25.00%
Nausea (feeling of having an urge to vomit): 3 people, 25.00%
Prostatic Dysplasia (enlargement of prostate): 3 people, 25.00%
Nightmares (unpleasant dreams): 3 people, 25.00%
Overdose: 3 people, 25.00%
Latent Autoimmune Diabetes In Adults (slow progressing diabetes in adult): 2 people, 16.67%
Insulin Resistance: 2 people, 16.67%
Weight Decreased: 2 people, 16.67%
Lipase Increased: 2 people, 16.67%

What are the existing conditions these people have? *

Hiv Infection: 11 people, 91.67%
Stress And Anxiety: 1 person, 8.33%
Spinal Disorder (disease of spine a back bone): 1 person, 8.33%
Seborrheic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 1 person, 8.33%
Rosacea (a skin condition that causes facial redness): 1 person, 8.33%
Rickets (softening of bones): 1 person, 8.33%
Muscle Spasms (muscle contraction): 1 person, 8.33%
Limb Discomfort (discomfort in leg): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
Erection Problems: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Pifeltro and have Dizziness?

- Check whether Dizziness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pifeltro:

Pifeltro (476 reports)

Dizziness treatments and more:

Dizziness (613,962 reports)

Browse all side effects of Pifeltro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dizziness:

Dizziness (3,571 drugs)

Browse all the conditions that are associated with Dizziness:

Dizziness (5,711 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on doravirine (the active ingredients of Pifeltro) and Pifeltro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.